Pfizer says vaccinating children with the COVID-19 vaccine is safe and about 91% effective at preventing infection in primary school children.
Details of the study were posted online Friday, as US regulators consider starting to vaccinate young people aged 5 to 11.
With regulatory approval, the shot could debut as early as next month—the first kids are fully protected by Christmas.
The Food and Drug Administration will post the company’s first review of safety and efficacy data later on Friday. Next week, FDA advisors will publicly discuss the evidence.
If the FDA approves the low-dose shots, the US Centers for Disease Control and Prevention will make final recommendations as to who should receive them.
Full-strength Pfizer shots are already allowed for everyone over the age of 12, but pediatricians and many parents prevent young children from developing the highly contagious delta variant and infection from children. Longing for security to help send the child to school.
The Associated Press’s Department of Health Sciences is supported by the Department of Science Education at the Howard Hughes Medical Institute. AP is solely responsible for all content.
Copyright 2021 AP Communications. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Pfizer says COVID-19 vaccine more than 90% effective in children
Source link Pfizer says COVID-19 vaccine is more than 90% effective in children